The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
P2X7Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis
Open accessAbstract
Oligodendrocyte death and demyelination are hallmarks of multiple sclerosis (MS). Here we show that ATP signaling can trigger oligodendrocyte excitotoxicity via activation of calcium-permeable P2X 7 purinergic receptors expressed by these cells. Sustained activation of P2X 7 receptors in vivo causes lesions that are reminiscent of the major features of MS plaques, i.e., demyelination, oligodendrocyte death, and axonal damage. In addition, treatment with P2X 7 antagonists of chronic experimental autoimmune encephalomyelitis (EAE), a model of MS, reduces demyelination and ameliorates the associated neurological symptoms. Together, these results indicate that ATP can kill oligodendrocytes via P2X 7 activation and that this cell death process contributes to EAE. Importantly, P2X 7 expression is elevated in normal-appearing axon tracts in MS patients, suggesting that signaling through this receptor in oligodendrocytes may be enhanced in this disease. Thus, P2X 7 receptor antagonists may be beneficial for the treatment of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Cell death and control of cell survival in the oligodendrocyte lineage
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345 · cited 2×
“Cells were maintained at 37°C and 5% CO2 in a chemically defined medium (Barres et al., 1992).”
MethodAltered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia
Káradóttir, R., Cavelier, P., Bergersen, L. H., & Attwell, D. (2005) · Nature · doi:10.1038/nature04302 · Cited by 772
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Khakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North, R. A., Séguéla, P., Voigt, M., & Humphrey, P. P. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01482-0 · Cited by 667
Multiple sclerosis: a two-stage disease
Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 593
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
P2X7Receptors Mediate ATP Release and Amplification of Astrocytic Intercellular Ca2+Signaling
Suadicani, S. O., Brosnan, C. F., & Scemes, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3902-05.2006 · Cited by 512
Bruyn, R. P. M. (2003) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00110-5 · Cited by 509
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia
Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., Yin, X., Trapp, B. D., McRory, J. E., Rehak, R., et al. (2006) · Nature · doi:10.1038/nature04474 · Cited by 505
P2X7 receptor inhibition improves recovery after spinal cord injury
Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1082 · Cited by 494
P2X 7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes
Duan, S., Anderson, C. M., Keung, E. C., Chen, Y., Chen, Y., & Swanson, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01320.2003 · Cited by 489
Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., & Posmantur, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209478200 · Cited by 488 · cited 3×
“…macrophages recruited during immune attack of the CNS, to release toxic agents including interleukin-1 (IL-1 ), tumor necrosis factor- , and superoxide and nitric oxide (Solle et al., 2001; Parvathenani et al., 2003; Block and Hong, 2005), all of which may contribute to oligodendrocyte demise.”
BackgroundAutoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Beyond the role of glutamate as a neurotransmitter
Nedergaard, M., Takano, T., & Hansen, A. J. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn916 · Cited by 450
Hetero-oligomeric Assembly of P2X Receptor Subunits
Torres, G. E., Egan, T. M., & Voigt, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6653 · Cited by 414
Brilliant Blue G Selectively Blocks ATP-Gated Rat P2X7Receptors
Jiang, L.-H., Mackenzie, A. B., North, R. A., & Surprenant, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.82 · Cited by 401
Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.
Murgia, M., Hanau, S., Pizzo, P., Rippa, M., & Di Virgilio, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53082-9 · Cited by 367
Molecular physiology of p2x receptors and atp signalling at synapses
Khakh, B. S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35058521 · Cited by 363
Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
Matute, C., Sánchez-Gómez, M. V., Martínez-Millán, L., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8830 · Cited by 352 · cited 1×
“Oligodendrocyte cultures were fixed in 4% paraformaldehyde in PBS and processed for immunocytochemistry as described previously (Matute et al., 1997).”
MethodSelf-citationThe link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
Self-citationGlial neuronal signaling in the central nervous system
Hansson, E., & Rönnbäck, L. (2003) · The FASEB Journal · doi:10.1096/fj.02-0429rev · Cited by 315
Contribution of Calcium Ions to P2X Channel Responses
Egan, T. M., & Khakh, B. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5429-03.2004 · Cited by 296
Hauser, S. L., Doolittle, T. H., Lincoln, R., Brown, R. H., & Dinarello, C. A. (1990) · Neurology · doi:10.1212/wnl.40.11.1735 · Cited by 265
Distinct Localization of P2X Receptors at Excitatory Postsynaptic Specializations
Rubio, M. E., & Soto, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00641.2001 · Cited by 260
James, G., & Butt, A. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01756-9 · Cited by 236
Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons
Anderson, C. M., & Nedergaard, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.003 · Cited by 207
The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes
Narcisse, L., Scemes, E., Zhao, Y., Lee, S. C., & Brosnan, C. F. (2005) · Glia · doi:10.1002/glia.20110 · Cited by 191
Somogyi, P., & Soltész, I. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90122-3 · Cited by 178
ATP stimulates calcium‐dependent glutamate release from cultured astrocytes
Jeremic, A., Jeftinija, K., Stevanovic, J., Glavaski, A., & Jeftinija, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00272.x · Cited by 177
Choi, H. B., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5417-06.2007 · Cited by 173
Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development
Agresti, C., Meomartini, M. E., Amadio, S., Ambrosini, E., Serafini, B., Franchini, L., Volonté, C., Aloisi, F., & Visentin, S. (2005) · Glia · doi:10.1002/glia.20160 · Cited by 166
Sánchez‐Gómez, M. V., Alberdi, E. M., Ibarretxe, G., Torre, I., & Matute, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09519.2003 · Cited by 154
Self-citationAMPA and Kainate Receptors Each Mediate Excitotoxicity in Oligodendroglial Cultures
Sánchez‐Gómez, M. V., & Matute, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0264 · Cited by 153
Self-citationEl-Moatassim, C., & Dubyak, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35890-3 · Cited by 153
Zamvil, S. S., & Steinman, L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00326-x · Cited by 149
Chen, L., & Brosnan, C. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3115 · Cited by 149
Increased expression and function of glutamate transporters in multiple sclerosis
Vallejo‐Illarramendi, A., Domercq, M., Pérez‐Cerdá, F., Ravid, R., & Matute, C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.017 · Cited by 145
Self-citationMultiple Sclerosis Pathology: Evolution of Pathogenetic Concepts
Lassmann, H. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00523.x · Cited by 132
Sperlágh, B., Haskó, G., Németh, Z., & Vizi, E. S. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00025-4 · Cited by 130
Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve
Matute, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10229 · Cited by 127
Self-citationRole of P2X 7 Receptors in Ischemic and Excitotoxic Brain Injury In Vivo
Feuvre, R. A. L., Brough, D., Touzani, O., & Rothwell, N. J. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048519.34839.97 · Cited by 122
Alberdi, E. M., Sánchez‐Gómez, M. V., Marino, A., & Matute, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0457 · Cited by 119
Self-citationGoldberg, M. P., & Ransom, B. R. (2003) · Stroke · doi:10.1161/01.str.0000054048.22626.b9 · Cited by 118
Multiple Sclerosis and Glutamate
Groom, A., Smith, T., & Turski, L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07533.x · Cited by 109
Chapter 29 The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor
Virgilio, F. D., Sanz, J. M., Chiozzi, P., & Falzoni, S. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63569-4 · Cited by 78
Seo, D. R., Kim, K. Y., & Lee, Y. B. (2004) · Neuroreport · doi:10.1097/00001756-200405190-00015 · Cited by 58
Chapter 22 Brain hypoxia: Effects of ATP and adenosine
Nieber, K., Eschke, D., & Brand, A. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63563-3 · Cited by 53
(1996) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1136(199606)17:2
(2002) · doi:10.14670/hh-17.1137
Cited by
Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
Alizadeh, A., Dyck, S. M., & Karimi-Abdolrezaee, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00282 · Cited by 1,407
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Purinergic signalling in the nervous system: an overview
Abbracchio, M. P., Burnstock, G., Verkhratsky, A., & Zimmermann, H. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.10.001 · Cited by 860
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
Metadata
- Authors
- Matute, C., Torre, I., Pérez-Cerdá, F., Pérez-Samartín, A., Alberdi, E., Etxebarria, E., Arranz, A. M., Ravid, R., Rodríguez-Antigüedad, A., Sánchez-Gómez, M., & Domercq, M.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-08-29
- Volume
- 27
- Issue
- 35
- Pages
- 9525-9533
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2019702139
- Cited by
- 405
- References
- 59
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.